Dalfampridine in the treatment of primary fatigue in patients with multiple sclerosis: a randomized clinical trail

ConclusionThe present study revealed a positive short-term effect of extended-release fampridine on MFIS in PwMS. However, this effect was not significantly superior to the placebo.
Source: Acta Neurologica Belgica - Category: Neurology Source Type: research